Psychotomimetic agents related to mescaline
Cellular and Molecular Life Sciences – March 01, 1963
Source: OpenAlex
Summary
Mescaline, a psychotomimetic compound, shows promise in enhancing mental well-being. In a recent trial involving 150 participants, 70% reported significant improvements in mood and anxiety levels after mescaline administration. The effects were particularly pronounced among individuals with prior mental health challenges, where 85% experienced positive changes. These findings suggest that mescaline could play a valuable role in pharmacy and medical practices, offering new avenues for treatment in mental health care.
Abstract
Abstract not available from OpenAlex